Virtu Financial’s Blueprint Medicines BPMC Stock Holding History

Virtu Financial’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,035	Closed	-$389K	–	1500
2025 Q2	$389K	Buy	+3,035	New	+$315K	0.02%	659
2022 Q3	–	Sell	-6,646	Closed	-$336K	–	1749
2022 Q2	$336K	Buy	+6,646	New	+$389K	0.03%	536
2021 Q1	–	Sell	-12,499	Closed	-$1.4M	–	1616
2020 Q4	$1.4M	Buy	+12,499	New	+$1.32M	0.15%	163
2019 Q4	–	Sell	-3,317	Closed	-$244K	–	1457
2019 Q3	$244K	Buy	+3,317	New	+$287K	0.02%	862
2019 Q2	–	Sell	-12,531	Closed	-$1M	–	1475
2019 Q1	$1M	Buy	+12,531	New	+$926K	0.06%	311

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Virtu Financial's BPMC Position: Q3 2025 in Review

Virtu Financial sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 3,035 shares — an estimated $389K sold.

Virtu Financial first reported a position in BPMC in Q1 2019 and held it in 5 quarters. The position peaked at $1.4M in Q4 2020. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Virtu Financial reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Virtu Financial sold 3,035 Blueprint Medicines shares in Q3 2025, an estimated $389K.
Virtu Financial first reported a position in Blueprint Medicines in Q1 2019 and held it in 5 quarters.
Virtu Financial's Blueprint Medicines position peaked at $1.4M in Q4 2020.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.